API australian pharmaceutical industries limited

News: API Australian Pharmaceutical Industries gets sweetened $560 mln buyout bid from Wesfarmers

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Sept 16 (Reuters) - Australian Pharmaceutical Industries (API) (API) said on Thursday it received a sweetened indicative bid from retail conglomerate Wesfarmers (WES) , valuing the pharmaceutical company at A$763.6 million ($560.25 million).

    As per the new bid, API shareholders would now receive A$1.55 per share, up from the previous offer of A$1.38 apiece that was rejected in July.

    ($1 = 1.3630 Australian dollars)

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.